PDA

View Full Version : Prostate Cancer Drug Shows Promise In Triple-Negative And Estrogen-Positive Breast Ca


News
12-05-2012, 02:23 AM
Breast cancers are defined by their drivers - estrogen and progesterone receptors (ER and PR) and HER2 are the most common, and there are drugs targeting each. When breast cancer has an unknown driver, it also has fewer treatment options - this aggressive form of breast cancer without ER, PR or HER2, which was thought not to be driven by hormones, is known as triple negative...

More... (http://www.medicalnewstoday.com/releases/253522.php)